World Largest and Top Pharmaceutical Companies List by Market Cap of July 2023

World Largest and Top Pharmaceutical Companies List by Market Cap of July-30-2023, World Biggest Pharmaceutical Companies by Market Cap, World Top Pharmaceutical Companies in the World by market cap as on July-30-2023.

  1. JOHNSON & JOHNSON

    World Rank (Jul-30-2023)
    15
    Market Cap (Jul-30-2023)
    453.43 Billion USD
    World Rank (Dec-25-2022)
    8
    Market Cap (Dec-25-2022)
    464.020 Billion USD
    World Rank (Jan-07-2022)
    14
    Market Cap (Jan-07-2022)
    457.940 Billion USD
    World Rank (Sep-01-2021)
    14
    Market Cap (Sep-01-2021)
    455.760 Billion USD
    World Rank (Jan-01-2021)
    14
    Market Cap (Jan-01-2021)
    414.310 Billion USD
    World Rank (Jan-2020)
    12
    Market Cap (Jan 1st 2020)
    383.148 Billion USD
    Annual Revenue in USD
    94,940 Million USD
    Annual Operating Income in USD
    23,700 Million USD
    Annual Net Income in USD
    17,940 Million USD
    Annual Results for Year ending in
    Dec-2022 month
    Headquarters State / City
    New Jersey
    Headquarters Country
    USA
    Company Business
    Healthcare
    Medical Equipment
    Pharmaceutical
    FMCG
    Biotechnology
    Stock Category
    Dow Jones Index (DJIA)
    S&P 500
    Stock Exchange
    NYSE
    Number of Employees
    155,800
    Employee Count as on Date
    As on Jan-2023
    Chairman
    William C. Weldon
    CEO:
    Joaquin Duato
    Company Website:
    Johnson & Johnson - Top Consumer Goods, Pharmaceuticals, Medical Devices Company
    Yahoo @ NYSE
    Wikipedia
    Facebook
    Rank in Country (Jan-2021)
    Company Rank in USA in 2021 is 9
    About Company Business:

    Johnson & Johnson is USA based company and it manufactures Consumer Goods, Medical Devices and Equipment and Pharmaceutical Products. As on December-2021, Johnson & Johnson has 141,700 employees across 60 countries. Headquarters is in USA. It is the the world’s largest and most broadly based healthcare company.

    As on December-2021, The Company’s subsidiaries operate 85 manufacturing facilities occupying approximately 15.0 million square feet of floor space for managing consumer goods, medical devices and pharmaceutical business segments.

       

      Facts About Company
      • Johnson & Johnson annual revenue generated for period ending Dec-2022 was 94.94 Billion USD.
      • Johnson & Johnson annual net income generated for period ending Dec-2022 was 17.94 Billion USD.
      • Johnson & Johnson annual revenue generated for period ending Dec-2021 was 93.77 Billion USD.
      • Johnson & Johnson annual net income generated for period ending Dec-2021 was 20.87 Billion USD.
      • Johnson & Johnson Dec-2020 ending annual Revenues in USA 43,133 Million USD
      • Johnson & Johnson Dec-2020 ending annual Revenues outside USA is 39,451 Million USD

      Johnson & Johnson annual sales - segment wise in 2019

      • Consumer segment annual sales in 2019 were 14,053 Million USD.
      • Pharmaceutical segment annual sales in 2019 were 45,572 Million USD.
      • Medical Devices segment annual sales in 2019 were 22,959 Million USD.
      Business Sector:
      Top Technology Companies in USA
      Top FMCG Companies in USA
      Top Healthcare Companies in USA
      Top Technology Companies in S&P 500
      Top Healthcare Companies in S&P 500
      Top Pharmaceutical Companies in USA
      Top Pharmaceutical Companies in S&P 500
      Company Rank in Country in 2022
      Company Rank in USA in 2022 is 11
      Read more

    • ELI LILLY AND COMPANY

      World Rank (Jul-30-2023)
      16
      Market Cap (Jul-30-2023)
      435.22 Billion USD
      World Rank (Dec-25-2022)
      19
      Market Cap (Dec-25-2022)
      349.570 Billion USD
      World Rank (Jan-07-2022)
      39
      Market Cap (Jan-07-2022)
      248.240 Billion USD
      World Rank (Sep-01-2021)
      40
      Market Cap (Sep-01-2021)
      247.070 Billion USD
      World Rank (Jan-01-2021)
      69
      Market Cap (Jan-01-2021)
      161.510 Billion USD
      World Rank (Jan-2020)
      82
      Market Cap (Jan 1st 2020)
      128.184 Billion USD
      Annual Revenue in USD
      28,541 Million USD
      Annual Operating Income in USD
      8,280 Million USD
      Annual Net Income in USD
      6,244 Million USD
      Annual Results for Year ending in
      Dec-2022 month
      Headquarters State / City
      Indiana
      Headquarters Country
      USA
      Company Business
      Healthcare
      Pharmaceutical
      Biotechnology
      HealthCare Products
      Healthcare Service
      Stock Category
      S&P 500
      Stock Exchange
      NYSE
      Bovespa Brazil
      Switzerland
      EURONEXT
      Number of Employees
      39,000
      Employee Count as on Date
      As on 2022
      Chairman
      Juan R. Luciano
      CEO:
      David A. Ricks
      Company Website:
      Eli Lilly And Company - Pharmaceutical Company
      Yahoo @ NYSE
      Wikipedia
      Facebook
      Rank in Country (Jan-2021)
      Company Rank in USA in 2021 is 43
      About Company Business:

      Eli Lilly is a healthcare and pharmaceutical and is USA based MNC company. Key business areas are Oncology, Bio-Medicines, Diabetes and also Animals Health.and Lilly unites caring with discovery to create medicines that make life better for people around the world.  Headquarters is in USA.

      Three long-established core values guide Lilly :

      • Integrity.
      • Excellence.
      • Respect for People.

      Facts About Lilly:

      • A heritage of more than 140 years: company founded on May 10, 1876

      • Headquarters located in Indianapolis, Indiana, U.S.A.

      • Approximately 33,000 employees worldwide

      • More than 7,800 employees engaged in research and development

      • Clinical research conducted in more than 55 countries

      • Research and development facilities located in 8 countries

      Facts About Company

      As on 2022, Eli Lilly has 39,000 employees.

      Eli Lilly annual revenue generated for period ending Dec-2022 was 28,541 million USD.

      Eli Lilly annual net income generated for period ending Dec-2022 was 6,244 million USD.

      Eli Lilly annual revenue generated for period ending Dec-2021 was 28,318 million USD.

      Eli Lilly annual net income generated for period ending Dec-2021 was 5,581 million USD.

      Business Sector:
      Top Technology Companies in USA
      Top Healthcare Companies in USA
      Top Technology Companies in S&P 500
      Top Healthcare Companies in S&P 500
      Top Pharmaceutical Companies in USA
      Top Pharmaceutical Companies in S&P 500
      Company Rank in Country in 2022
      Company Rank in USA in 2022 is 25
      Read more

    • NOVO NORDISK A/S

      World Rank (Jul-30-2023)
      24
      Market Cap (Jul-30-2023)
      356.92 Billion USD
      World Rank (Dec-25-2022)
      27
      Market Cap (Dec-25-2022)
      301.520 Billion USD
      World Rank (Jan-07-2022)
      50
      Market Cap (Jan-07-2022)
      231.350 Billion USD
      World Rank (Sep-01-2021)
      46
      Market Cap (Sep-01-2021)
      229.040 Billion USD
      World Rank (Jan-01-2021)
      66
      Market Cap (Jan-01-2021)
      163.070 Billion USD
      World Rank (Jan-2020)
      69
      Market Cap (Jan 1st 2020)
      137.602 Billion USD
      Annual Revenue in USD
      26,157 Million USD
      Annual Operating Income in USD
      11,058 Million USD
      Annual Net Income in USD
      8,208 Million USD
      Annual Results for Year ending in
      Dec-2022 month
      Headquarters State / City
      Bagsvaerd
      Headquarters Country
      Denmark
      Company Business
      Healthcare
      Pharmaceutical
      Biotechnology
      HealthCare Products
      Healthcare Service
      Stock Category
      S&P EUROPE 350
      Stock Exchange
      NYSE
      Number of Employees
      55,185
      Employee Count as on Date
      As on 2022
      Chairman
      Helge Lund
      CEO:
      Lars Fruergaard Jorgensen
      Company Website:
      Novo Nordisk - Pharmaceutical Company
      Yahoo @ NYSE
      Wikipedia
      Facebook
      About Company Business:

      Novo Nordisk is Denmark based Multinational Pharmaceutical Company. Novo Nordisk is a global healthcare company with more than 90 years of innovation and leadership in diabetes care. Headquarters is in Denmark.

      Novo Nordisk employs approximately 55,185 employees in 79 countries as on 2022 and markets its products in more than 170 countries.

      Facts About Company

      For year ending December-2022, Novo Nordisk Annual Revenue was 176,954 Million DKK and Net Income was 55,525 Million DKK.

      For year ending December-2021, Novo Nordisk Annual Revenue was 140,800 Million DKK and Net Income was 47,757 Million DKK.

      Business Sector:
      Top Healthcare Companies in Europe
      Top Technology Companies in Europe
      Top Pharmaceutical Companies in Europe
      Company Rank in Country in 2022
      Company Rank in Denmark in 2022 is 1
      Read more

    • MERCK & CO

      World Rank (Jul-30-2023)
      32
      Market Cap (Jul-30-2023)
      269.83 Billion USD
      World Rank (Dec-25-2022)
      30
      Market Cap (Dec-25-2022)
      283.610 Billion USD
      World Rank (Jan-07-2022)
      59
      Market Cap (Jan-07-2022)
      202.830 Billion USD
      World Rank (Sep-01-2021)
      62
      Market Cap (Sep-01-2021)
      193.120 Billion USD
      World Rank (Jan-01-2021)
      42
      Market Cap (Jan-01-2021)
      206.960 Billion USD
      World Rank (Jan-2020)
      32
      Market Cap (Jan 1st 2020)
      231.557 Billion USD
      Annual Revenue in USD
      59,280 Million USD
      Annual Operating Income in USD
      18,280 Million USD
      Annual Net Income in USD
      14,510 Million USD
      Annual Results for Year ending in
      Dec-2022 month
      Headquarters State / City
      New Jersey
      Headquarters Country
      USA
      Company Business
      Healthcare
      Pharmaceutical
      Animal Healthcare Companies
      Animal Health Medicine
      Biotechnology
      Stock Category
      Dow Jones Index (DJIA)
      S&P 500
      S&P EUROPE 350
      Stock Exchange
      NYSE
      EURONEXT
      Number of Employees
      69,000
      Employee Count as on Date
      As on 2022
      Chairman
      Kenneth C. Frazier
      CEO:
      Robert M. Davis
      Company Website:
      Merck - Healthcare and Pharmaceutical Company
      Yahoo @ NYSE
      Wikipedia
      Facebook
      Rank in Country (Jan-2021)
      Company Rank in USA in 2021 is 26
      About Company Business:

      Merck & Co is USA based healthcare and pharmaceutical multi-national company. Merck Company makes a difference in the lives of people globally through their innovative medicines, vaccines, and animal health products. Headquarters is in USA. Merck & Co focus on scientific innovation to deliver medicines and vaccines that may help millions of people around the world.

      Facts About Company

      As on 2022, Merck & Co has 69,000 employees.

      Merck & Co annual revenue generated for period ending Dec-2022 was 59.28 billion USD.

      Merck & Co annual net income generated for period ending Dec-2022 was 14.51 billion USD.

      Merck & Co annual revenue generated for period ending Dec-2021 was 48.70 million USD.

      Merck & Co annual net income generated for period ending Dec-2021 was 13.04 million USD.

      Total Assets as on Dec-2020 was 91,588 Million USD.

      Business Sector:
      Top Technology Companies in USA
      Top Healthcare Companies in USA
      Top Technology Companies in S&P 500
      Top Healthcare Companies in S&P 500
      Top Pharmaceutical Companies in USA
      Top Pharmaceutical Companies in S&P 500
      Company Rank in Country in 2022
      Company Rank in USA in 2022 is 42
      Read more

    • ABBVIE

      World Rank (Jul-30-2023)
      33
      Market Cap (Jul-30-2023)
      266.14 Billion USD
      World Rank (Dec-25-2022)
      29
      Market Cap (Dec-25-2022)
      288.440 Billion USD
      World Rank (Jan-07-2022)
      46
      Market Cap (Jan-07-2022)
      238.450 Billion USD
      World Rank (Sep-01-2021)
      53
      Market Cap (Sep-01-2021)
      213.440 Billion USD
      World Rank (Jan-01-2021)
      51
      Market Cap (Jan-01-2021)
      189.100 Billion USD
      World Rank (Jan-2020)
      76
      Market Cap (Jan 1st 2020)
      131.674 Billion USD
      Annual Revenue in USD
      58,054 Million USD
      Annual Operating Income in USD
      18,814 Million USD
      Annual Net Income in USD
      11,782 Million USD
      Annual Results for Year ending in
      Dec-2022 month
      Headquarters State / City
      Illinois
      Headquarters Country
      USA
      Company Business
      Healthcare
      Pharmaceutical
      Biotechnology
      HealthCare Products
      Healthcare Service
      Stock Category
      S&P 500
      Stock Exchange
      NYSE
      Number of Employees
      50,000
      Employee Count as on Date
      As on Jan-2023
      CEO:
      Richard A. Gonzalez
      Company Website:
      Abbvie - Healthcare and Bio-Pharmaceutical Company
      Yahoo @ NYSE
      Wikipedia
      Facebook
      Rank in Country (Jan-2021)
      Company Rank in USA in 2021 is 34
      About Company Business:

      Abbvie is USA based healthcare and pharmaceutical multi-national company that takes on the toughest health challenges. Abbvie do more than treat diseases and they aim to make a remarkable impact on people’s lives. AbbVie is highly focus research-driven bio-pharmaceutical company. Headquarters is in USA.

      Facts About Company

      As on 2023, Abbvie has 50,000 employees.

      Abbvie annual revenue generated for period ending Dec-2022 was 58,054  million USD.

      Abbvie annual net income generated for period ending Dec-2022 was 11,782 million USD.

      As on 2020, Abbvie has 47,000 employees who are scientists, researchers, communicators, manufacturing specialists and regulatory experts located around the globe.

      Abbvie  annual revenue generated for period ending Dec-2021 was 56,197 million USD.

      Abbvie annual net income generated for period ending Dec-2021 was 11,542 million USD.

      Total Assets as on Dec-2021 was 146,529 Million USD.

      Business Sector:
      Top Technology Companies in USA
      Top Healthcare Companies in USA
      Top Technology Companies in S&P 500
      Top Healthcare Companies in S&P 500
      Top Pharmaceutical Companies in USA
      Top Pharmaceutical Companies in S&P 500
      Company Rank in Country in 2022
      Company Rank in USA in 2022 is 32
      Read more

    • ROCHE HOLDING AG

      World Rank (Jul-30-2023)
      38
      Market Cap (Jul-30-2023)
      249.73 Billion USD
      World Rank (Dec-25-2022)
      32
      Market Cap (Dec-25-2022)
      261.410 Billion USD
      World Rank (Jan-07-2022)
      25
      Market Cap (Jan-07-2022)
      356.150 Billion USD
      World Rank (Sep-01-2021)
      21
      Market Cap (Sep-01-2021)
      350.650 Billion USD
      World Rank (Jan-01-2021)
      25
      Market Cap (Jan-01-2021)
      295.780 Billion USD
      World Rank (Jan-2020)
      23
      Market Cap (Jan 1st 2020)
      279.684 Billion USD
      Annual Revenue in USD
      72,691 Million USD
      Annual Operating Income in USD
      20,068 Million USD
      Annual Net Income in USD
      14,267 Million USD
      Annual Results for Year ending in
      Dec-2022 month
      Headquarters State / City
      Basel
      Headquarters Country
      Switzerland
      Company Business
      Healthcare
      Pharmaceutical
      Medical Equipment
      Biotechnology
      Healthcare Service
      Stock Category
      S&P EUROPE 350
      Stock Exchange
      Switzerland
      Number of Employees
      103,613
      Employee Count as on Date
      As on 2022
      Chairman
      Christoph Franz
      CEO:
      Severin Schwan
      Company Website:
      Roche - Healthcare and Pharmaceutical Company
      Yahoo @ Switzerland
      Wikipedia
      Rank in Country (Jan-2021)
      Company Rank in Switzerland in 2021 is 2
      Billionaires related to Enterprise:
      Andre Hoffmann
      Andreas Oeri
      Maja Oeri
      Catherine Oeri
      Jorg Duschmale
      Sabine Duschmale Oeri
      Vera Michalski Hoffmann
      Lukas Duschmale
      Maja Hoffmann
      About Company Business:

      Roche Holding is a pioneer in Healthcare Company with headquarters in Basel, Switzerland. Over half of the compounds in Roche Company products pipeline are biopharmaceuticals, enabling them to deliver better-targeted therapies. They are specialized in Oncology, Neuroscience, Infectious Diseases, Immunology, Cardiovascular and Metabolism, Opthamology and Respiratory branches Medicines.

      Facts About Company

      Roche Holding annual revenues for year ending December 2022 was 63.28 billion CHF. (Previous year : 62.8 billion CHF)

      Roche Holding annual operating profit for year ending December 2022 is 17.47 billion CHF. (Previous year : 18.15 billion CHF)

      As on December 2022, Roche Holding has 103,613 employees, 29 research and development sites in Pharmaceuticals and Diagnostics worldwide, 23 manufacturing sites in Pharmaceuticals and Diagnostics worldwide.

      63 million patients treated with medicines of Roche Holding.

      Business Sector:
      Top Healthcare Companies in Europe
      Top Technology Companies in Europe
      Top Pharmaceutical Companies in Europe
      Company Rank in Country in 2022
      Company Rank in Switzerland in 2022 is 2
      Read more

    • ASTRAZENECA

      World Rank (Jul-30-2023)
      44
      Market Cap (Jul-30-2023)
      221.35 Billion USD
      World Rank (Dec-25-2022)
      40
      Market Cap (Dec-25-2022)
      210.670 Billion USD
      World Rank (Jan-07-2022)
      71
      Market Cap (Jan-07-2022)
      178.120 Billion USD
      World Rank (Sep-01-2021)
      69
      Market Cap (Sep-01-2021)
      181.450 Billion USD
      World Rank (Jan-01-2021)
      93
      Market Cap (Jan-01-2021)
      130.990 Billion USD
      World Rank (Jan-2020)
      72
      Market Cap (Jan 1st 2020)
      135.300 Billion USD
      Annual Revenue in USD
      44,351 Million USD
      Annual Operating Income in USD
      4,561 Million USD
      Annual Net Income in USD
      3,288 Million USD
      Annual Results for Year ending in
      Dec-2022 month
      Headquarters State / City
      Cambridge
      Headquarters Country
      UK
      Company Business
      Healthcare
      Pharmaceutical
      Biopharmaceutical
      Biotechnology
      HealthCare Products
      Stock Category
      Nasdaq 100
      FTSE 100
      S&P EUROPE 350
      UK ADRs
      Stock Exchange
      NYSE
      Stockholm
      LSE
      Number of Employees
      83,500
      Employee Count as on Date
      As on 2022
      ISIN Code:
      GB0009895292
      Chairman
      Leif Johansson
      CEO:
      Pascal Soriot
      Company Website:
      Astrazeneca - Healthcare and Pharamaceutical Company
      Yahoo @ NYSE
      Wikipedia
      Rank in Country (Jan-2021)
      Company Rank in UK in 2021 is 4
      About Company Business:

      AstraZeneca is UK Based Pharmaceutical and Bio-Technology Company. They have done some advanced research on Oncology. In the fight against COVID-19, Astrazeneca is one among World Top 5 Companies which has done advanced phase of Covid-19 testing in collaboration with the University of Oxford and are launching Phase III trials. Headquarters is in UK.

      AstraZeneca Product Sales split by Disease Area for year ending Dec-2021

      Facts About Company

      AstraZeneca annual revenue was 44,351 million USD for year ending Dec-2022 and annual operating profit was 3,757 million USD and annual net income was 3,288 million USD for year ending Dec-2022.

      AstraZeneca has 83,500 employees as on 2022 when compared to with 76,100 employees as on 2020 and 70,600 employees as on 2019.

      AstraZeneca has total assets of 96,483 million USD as on Dec-2022 when compared to 66,729 million USD as on Dec-2020.

      AstraZeneca Product Sales split of 44,351 Million USD by Disease Area for year ending Dec-2022

      • 11,745 Million USD from Emerging Markets (Previous year  12,281  million USD)
      • 17,920 Million USD from USA.  (Previous year 2021 : 12,228 million USD)
      • 8,738 Million USD from Europe. (Previous year 2021 : 8,050 million USD)
      • From the rest of the World, it is 5,948 Million USD (Previous year 2021 : 4,858 million USD)

      As on December-2022, Astrazeneca has 83,500 employees and out of that

      • 16,500 employees are from USA.
      • 10,700 employees are from UK
      • 16,500 employees are from China
      • 7,100 employees are from Sweden
      • 11,400 employees are from Other Europe has 
      • 7,200 employees are from Other Asia Pacific
      • 1,200 employees are from Canada and 2,400 employees are from Middle East and Africa and 2,000 employees are from Russia and 3,500 employees are from Japan and 1,000 employees are from Australia and New Zealand.

      Astrazeneca company acquired Alexion Pharmaceuticals for 39 Billion USD in 2020.

      Business Sector:
      Top Healthcare Companies in UK
      Top Technology Companies in UK
      Top Healthcare Companies in Europe
      Top Technology Companies in Europe
      Top Pharmaceutical Companies in Europe
      Company Rank in Country in 2022
      Company Rank in UK in 2022 is 1
      Read more

    • NOVARTIS AG

      World Rank (Jul-30-2023)
      45
      Market Cap (Jul-30-2023)
      220.82 Billion USD
      World Rank (Dec-25-2022)
      47
      Market Cap (Dec-25-2022)
      195.460 Billion USD
      World Rank (Jan-07-2022)
      61
      Market Cap (Jan-07-2022)
      201.260 Billion USD
      World Rank (Sep-01-2021)
      55
      Market Cap (Sep-01-2021)
      206.760 Billion USD
      World Rank (Jan-01-2021)
      39
      Market Cap (Jan-01-2021)
      217.770 Billion USD
      World Rank (Jan-2020)
      38
      Market Cap (Jan 1st 2020)
      215.018 Billion USD
      Annual Revenue in USD
      51,830 Million USD
      Annual Operating Income in USD
      9,190 Million USD
      Annual Net Income in USD
      6,950 Million USD
      Annual Results for Year ending in
      Dec-2022 month
      Headquarters State / City
      Basel
      Headquarters Country
      Switzerland
      Company Business
      Healthcare
      Pharmaceutical
      Biotechnology
      HealthCare Products
      Healthcare Service
      Stock Category
      S&P EUROPE 350
      Stock Exchange
      NYSE
      Switzerland
      Number of Employees
      101,703
      Employee Count as on Date
      As on 2022
      Chairman
      Joerg Reinhardt
      CEO:
      Vasant Narasimhan
      Company Website:
      Novartis - Healthcare and Pharmaceutical Companies in World
      Yahoo @ NYSE
      Wikipedia
      Facebook
      Rank in Country (Jan-2021)
      Company Rank in Switzerland in 2021 is 3
      About Company Business:

      Novartis is Switzerland based Multi-National Healthcare and Pharmaceutical company. Novartis Company focus on patented medicines, generic medicines and eye care – segments where they have the innovation power and global scale necessary to compete effectively. At the same time, Novartis is expanding their presence in the emerging markets of Asia, Africa and Latin America, where there is fast-growing demand for access to high- quality medicines and healthcare. 

      Facts About Company

      Novartis annual revenue was 51.83 billion USD for year ending Dec-2022 and annual operating profit was 9.19 billion USD and annual net income was 6.95 billion USD for the same period.

      Novartis had over 101,703 employees worldwide as on 2022.

      Split of Novartis annual revenue 50,545 billion USD for year ending Dec-2022, Innovative Medicines business segment earned 41,296 million USD revenue and Sandoz business segment earned 9,249 million USD revenue.

      Within the Innovative Medicines business segment:
      Cardiovascular division earned 4,756 million USD revenue.
      Immunology division earned 7,287 million USD revenue.
      Neuroscience division earned 5,051 million USD revenue.
      Solid Tumors division earned 4,723 million USD revenue.
      Hematology division earned 6,452 million USD revenue.
      Other Promoted Brands division earned 3,127 million USD revenue.
      Established Brands division earned 9,900 million USD revenue.

      Business Sector:
      Top Healthcare Companies in Europe
      Top Technology Companies in Europe
      Top Pharmaceutical Companies in Europe
      Company Rank in Country in 2022
      Company Rank in Switzerland in 2022 is 3
      Read more

    • THERMO FISHER SCIENTIFIC

      World Rank (Jul-30-2023)
      48
      Market Cap (Jul-30-2023)
      216.72 Billion USD
      World Rank (Dec-25-2022)
      39
      Market Cap (Dec-25-2022)
      212.050 Billion USD
      World Rank (Jan-07-2022)
      45
      Market Cap (Jan-07-2022)
      239.220 Billion USD
      World Rank (Sep-01-2021)
      50
      Market Cap (Sep-01-2021)
      219.270 Billion USD
      World Rank (Jan-01-2021)
      54
      Market Cap (Jan-01-2021)
      184.600 Billion USD
      World Rank (Jan-2020)
      74
      Market Cap (Jan 1st 2020)
      132.528 Billion USD
      Annual Revenue in USD
      44,915 Million USD
      Annual Operating Income in USD
      8,507 Million USD
      Annual Net Income in USD
      6,950 Million USD
      Annual Results for Year ending in
      Dec-2022 month
      Headquarters State / City
      Massachusetts
      Headquarters Country
      USA
      Company Business
      Healthcare
      Medical Equipment
      Pharmaceutical
      Technology Hardware and Instruments
      Electronics
      Stock Category
      S&P 500
      Stock Exchange
      NYSE
      Bovespa Brazil
      Number of Employees
      130,000
      Employee Count as on Date
      As on Dec-2022
      CEO:
      Marc N. Casper
      Company Website:
      THERMO FISHER SCIENTIFIC INC
      Yahoo @ NYSE
      Wikipedia
      Facebook
      Rank in Country (Jan-2021)
      Company Rank in USA in 2021 is 36
      About Company Business:

      Thermo Fisher Scientific is USA Based Bio-Technology and Healthcare Company. Develops and manufactures Medical Equipment. Headquarters is in USA.

      Facts About Company

      As on 2022, Thermo Fisher Scientific has 130,000 employees.

      Thermo Fisher Scientific annual revenue generated for period ending Dec-2022 was 44,915 million USD.

      Thermo Fisher Scientific annual net income generated for period ending Dec-2022 was 6,950 million USD.

      For Year ending December-2021, Thermo Fisher Scientific annual revenues is 39,211 Million USD and Net Income is 7,725 Million USD.

      As on December-2020, they had 80,000 employees.

      Business Sector:
      Top Technology Companies in USA
      Top Electronics Companies in USA
      Top Software and IT Companies in USA
      Top Healthcare Companies in USA
      Top Technology Companies in S&P 500
      Top Pharmaceutical Companies in USA
      Top Pharmaceutical Companies in S&P 500
      Company Rank in Country in 2022
      Company Rank in USA in 2022 is 31
      Read more

    • PFIZER

      World Rank (Jul-30-2023)
      53
      Market Cap (Jul-30-2023)
      203.63 Billion USD
      World Rank (Dec-25-2022)
      28
      Market Cap (Dec-25-2022)
      290.940 Billion USD
      World Rank (Jan-07-2022)
      27
      Market Cap (Jan-07-2022)
      312.750 Billion USD
      World Rank (Sep-01-2021)
      36
      Market Cap (Sep-01-2021)
      258.300 Billion USD
      World Rank (Jan-01-2021)
      46
      Market Cap (Jan-01-2021)
      204.600 Billion USD
      World Rank (Jan-2020)
      37
      Market Cap (Jan 1st 2020)
      215.483 Billion USD
      Annual Revenue in USD
      100,330 Million USD
      Annual Operating Income in USD
      37,270 Million USD
      Annual Net Income in USD
      31,370 Million USD
      Annual Results for Year ending in
      Dec-2022 month
      Headquarters State / City
      New York
      Headquarters Country
      USA
      Company Business
      Healthcare
      Pharmaceutical
      HealthCare Products
      Biotechnology
      Technology
      Stock Category
      S&P 500
      Stock Exchange
      NYSE
      Number of Employees
      83,000
      Employee Count as on Date
      As on 2022
      Chairman
      Albert Bourla
      CEO:
      Albert Bourla
      Company Website:
      Pfizer - Top Pharmaceutical Company
      Yahoo @ NYSE
      Wikipedia
      Facebook
      Rank in Country (Jan-2021)
      Company Rank in USA in 2021 is 29
      About Company Business:

      Pfizer is one of World's Top Pharmaceutical company and its headquarters is in New York, USA. Pfizer Products and Medicines are the results of 1500 scientists overseeing more than 500,000 lab tests and over 36 clinical trials before the first prescription. Pfizer develops medicines from simple diseases to most complex diseases in the world and their products are pharmaceutical drugs, vaccines.

       

      Facts About Company

      As on 2022, Pfizer has 83,000 employees.

      Pfizer annual revenue generated for period ending Dec-2022 was 100.33 billion USD.

      Pfizer annual net income generated for period ending Dec-2022 was 31.37 billion USD.

      As om 2021, Pfizer  has 79,000 employees.

      Pfizer  annual revenue generated for period ending Dec-2021 was 81.28 million USD.

      Pfizer  annual net income generated for period ending Dec-2021 was 21.98 million USD.

      Business Sector:
      Top Technology Companies in USA
      Top Healthcare Companies in USA
      Top Technology Companies in S&P 500
      Top Healthcare Companies in S&P 500
      Top Pharmaceutical Companies in USA
      Top Pharmaceutical Companies in S&P 500
      Company Rank in Country in 2022
      Company Rank in USA in 2022 is 18
      Read more

    Displaying 1 - 10 of 650 Top Companies List.

    World Largest and Top 500 Pharmaceutical Companies in 2023
    World Top 500 Pharmaceutical Companies by Market Cap in 2023, World Largest 500 Pharmaceutical Companies by Market Cap in 2023.
    World Top 500 Pharmaceutical Companies by Market Cap in 2023, World Largest 500 Pharmaceutical Companies by Market Cap in 2023.

    World Top 500 Pharmaceutical Companies by Market Cap in 2023, World Largest 500 Pharmaceutical Companies by Market Cap in 2023.

    World Largest and Top Pharmaceutical Companies List by Market Cap in 2023

    Market Capitalization of any company on any day = (Total number of shares in company) * (Stock Price on that particular day)

    Share it on Social Media